Injury - 2026-06-24 - Journal Article
The impact of duration of infection on outcome of debridement, antimicrobial treatment and implant retention in fracture-related infections of the lower leg: A multicentre retrospective cohort study.
Sliepen J, Buijs MAS, Wouthuyzen-Bakker M, Depypere M, Rentenaar RJ, De Vries JPPM, Onsea J, Morgenstern M, Muri T, Metsemakers WJ, Govaert GAM, IJpma FFA
Topics
Key Takeaway
DAIR for lower leg fracture-related infection achieved only 57% treatment success (implant retention + infection eradication + fracture healing + limb preservation), with no significant association between time to DAIR and outcome up to 9 weeks (HR 1.01, 95%CI 1.00–1.03, p=0.059).
Summary Depth
Choose how much analysis to show on this article page.
Summary
This multinational retrospective cohort study examined whether the interval from fracture fixation to DAIR (FF-FRI interval) predicts treatment success in lower leg fracture-related infections treated within 12 weeks of fixation. Among 100 patients with a median FF-FRI interval of 17 days, multivariable analysis showed no statistically significant effect of the FF-FRI interval on outcome (HR 1.01, p=0.059). Overall treatment success using a composite endpoint was 57%, and 50% of recurrent infections yielded identical pathogens.
Key Limitation
The study is underpowered at n=100 with a p-value of 0.059 for the primary exposure, meaning a clinically relevant time-dependent effect cannot be excluded, and the retrospective design introduces selection bias in which patients were offered DAIR versus implant exchange.
Original Abstract
AIM
This study aimed to assess the association between the interval from initial fracture fixation to debridement, antibiotics and implant retention (DAIR) for fracture-related infection (FRI) (referred to as the FF-FRI interval) and treatment outcome in patients with FRI of the lower leg.
METHODS
This multinational retrospective cohort study included patients over 18-years of age who were diagnosed with an FRI of the lower leg, who underwent FRI surgery within 12 weeks after initial fracture fixation, between January 1st 2015 and July 1st 2020. All patients had a minimum follow-up of 12 months after cessation of therapy. Treatment success was defined as a combination of implant retention, eradication of infection, fracture healing and preservation of the affected limb. Both univariate and multivariable models were employed to ascertain factors associated with treatment outcome following DAIR.
RESULTS
A total of 100 patients were treated with DAIR. The median FF-FRI interval was 17 days (range: 1-63). A total of 57/100 patients (57%) had a successful treatment outcome after a median follow-up of 33.6 (P 25 -P 75 : 18.4-50.7) months. In 11 out of 22 patients (50%) identical pathogens were cultured at time of recurrent infection. The multivariable analysis demonstrated no statistically significant effect of the FF-FRI interval (HR: 1.01; 95%CI: [1.00-1.03]; p: 0.059).
CONCLUSION
This study found no association between time to DAIR surgery and treatment outcome of DAIR procedures up to nine weeks, in patients with an FRI of the lower leg, however the success rate, when applying strict definition of treatment success, of 57% rate is limited. In clinical practice, this indicates that attempts to retain an implant can be considered at least up to nine weeks after initial fracture fixation, provided that other surgical decision-making factors (e.g. implant stability, adequate debridement, and soft tissue coverage) permit it.